ArticleClinical journal of the American Society of Nephrology : CJASN2020
Particulate Matter and Albuminuria, Glomerular Filtration Rate, and Incident CKD.
Article in Clinical journal of the American Society of Nephrology : CJASN, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers, 4 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
47 citing papers in PubMed, 4 syntheses or guidelines pooled it, 107 citations in OpenAlex.
- Association of fine particulate matter (PMScientific reports · 2024Pooled it
- Adverse Effects of fine particulate matter on human kidney functioning: a systematic review.Environmental health : a global access science source · 2022Pooled it
- Efficacy and safety of eplerenone treatment for patients with diabetic nephropathy: A meta-analysis.PloS one · 2022Pooled it
- Modifiable Lifestyle Factors for Primary Prevention of CKD: A Systematic Review and Meta-Analysis.Journal of the American Society of Nephrology : JASN · 2021Pooled it
- Particulate Matter Exposure and Diabetic Kidney Dysfunction: Insights from Integrated Transcriptomic and Bioinformatics Analyses.International journal of molecular sciences · 2026Article
- Global and national burden of chronic kidney disease attributable to fine particles: An updated exposure-response meta-analysis.Innovation (Cambridge (Mass.)) · 2026Article
- Long-term exposure to air pollution and chronic kidney disease incidence in adults: The Danish Nurse Cohort.Journal of exposure science & environmental epidemiology · 2026Article
- Atmospheric stressors and kidney diseases.Nature reviews. Nephrology · 2026Review
- Epidemiology of cardiovascular-kidney-metabolic syndrome.Nature reviews. Nephrology · 2026Review
- Chronic PMScientific reports · 2026Article
- Spatiotemporal Heterogeneity and the Impact of PM1 and Nitrogen Oxides on Chronic Kidney Disease Mortality in 39 European Countries (1990-2022): A Multi-Model Analysis.International journal of nephrology and renovascular disease · 2026Article
- Air Pollution, Kidney Injury, and Green Nephrology-Thinking About Its Association and Causation.Journal of clinical medicine · 2025Review
- From Plants to Protection: Cardiorenal Benefits in Non-Diabetic Chronic Kidney Disease and Heart Failure.Molecules (Basel, Switzerland) · 2025Review
- Particulate matter exposure and end-stage renal disease risk in IgA nephropathy.Frontiers of medicine · 2025Article
- Article
- Long-term impact of PMClinical kidney journal · 2025Article
- Elevated exposure to air pollutants accelerates primary glomerular disease progression.Clinical kidney journal · 2025Review
- Article
- Global burden of peripheral arterial disease (1990-2021), global burden trends and the impact of blood lead on peripheral arterial disease: a multidimensional analysis based on NHANES, GBD, and Mendelian randomization.Journal of translational medicine · 2025Article
- Air pollution-associated chronic kidney disease (APA-CKD): evidence from a cross-sectional study of Niger Delta communities.BMJ open · 2025Article
Corrections and comments
- Commented on by
Authors and funding
8 authors at 4 institutions in 1 country.
Funding
Abstract
BACKGROUND AND
objectivesExposure to particulate matter (PM) <2.5 DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: The study included 10,997 participants from the Atherosclerosis Risk in Communities cohort who were followed from 1996-1998 through 2016. Monthly mean PM
resultsBaseline mean participant age was 63 (±6) years and eGFR was 86 (±16) ml/min per 1.73 m
conclusionsExposure to higher annual average PM
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.